<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7(8)</volume><submitter>Meng Z</submitter><pubmed_abstract>&lt;h4>Background &amp; aims&lt;/h4>Cellular heterogeneity of innate immune cells, such as macrophages, in the liver is a hallmark of metabolic dysfunction-associated steatohepatitis (MASH) pathogenesis. However, the mechanisms shaping liver macrophage heterogeneity and function during disease progression remain poorly understood.&lt;h4>Methods&lt;/h4>Control or myeloid-specific &lt;i>Tgfbr1&lt;/i> knockout mice (n = 9-12 per group) were fed a 12-week choline-deficient, amino acid-defined high-fat diet (CDA-HFD) or a 20-week GAN diet (40% fat, 22% fructose, 2% cholesterol). Liver tissue was analyzed using histopathology, quantitative PCR, immunoblotting, flow cytometry, and RNA sequencing (RNA-seq). Bulk RNA-seq (n = 3 per group) and single-nucleus RNA-seq were performed to investigate transcriptional reprogram</pubmed_abstract><journal>JHEP reports : innovation in hepatology</journal><pagination>101488</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12284356</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Myeloid TGF-β signaling shapes liver macrophage heterogeneity and metabolic liver disease pathogenesis.</pubmed_title><pmcid>PMC12284356</pmcid><pubmed_authors>Lee YT</pubmed_authors><pubmed_authors>Zhou L</pubmed_authors><pubmed_authors>Qiu X</pubmed_authors><pubmed_authors>Lin JD</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Chen Z</pubmed_authors><pubmed_authors>Lu Y</pubmed_authors><pubmed_authors>Gallagher KA</pubmed_authors><pubmed_authors>Levi B</pubmed_authors><pubmed_authors>Meng Z</pubmed_authors><pubmed_authors>Liu T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Myeloid TGF-β signaling shapes liver macrophage heterogeneity and metabolic liver disease pathogenesis.</name><description>&lt;h4>Background &amp; aims&lt;/h4>Cellular heterogeneity of innate immune cells, such as macrophages, in the liver is a hallmark of metabolic dysfunction-associated steatohepatitis (MASH) pathogenesis. However, the mechanisms shaping liver macrophage heterogeneity and function during disease progression remain poorly understood.&lt;h4>Methods&lt;/h4>Control or myeloid-specific &lt;i>Tgfbr1&lt;/i> knockout mice (n = 9-12 per group) were fed a 12-week choline-deficient, amino acid-defined high-fat diet (CDA-HFD) or a 20-week GAN diet (40% fat, 22% fructose, 2% cholesterol). Liver tissue was analyzed using histopathology, quantitative PCR, immunoblotting, flow cytometry, and RNA sequencing (RNA-seq). Bulk RNA-seq (n = 3 per group) and single-nucleus RNA-seq were performed to investigate transcriptional reprogram</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-03-16T04:08:17.116Z</modification><creation>2025-08-14T03:05:50.92Z</creation></dates><accession>S-EPMC12284356</accession><cross_references><pubmed>40704067</pubmed><doi>10.1016/j.jhepr.2025.101488</doi></cross_references></HashMap>